| Name | Title | Contact Details |
|---|
Synonym is accelerating the worlds biological future by developing, financing and building commercial-scale biomanufacturing facilities. We provide synthetic biology (synbio) producers – from startups to the Fortune 500 – with flexible production capacity while giving infrastructure investors access to a new, carbon-negative biomanufacturing asset class that we are calling "fermentation farms".
ClearView Healthcare Partners is a global strategy consulting firm focused on the life sciences sector. Founded in 2007 in Boston, the company provides strategic advice across various therapeutic areas and technologies. ClearView combines scientific expertise with analytical rigor to help clients develop growth strategies at the product, franchise, and corporate levels. The firm operates globally, with offices in North America, including Boston, New York, and San Francisco, and has expanded into Europe with locations in London and Zurich. ClearView offers a range of services, including market analysis, launch strategy development, pricing strategies, and advanced analytics, tailored to support pharmaceutical, biotechnology, medical device, and diagnostics companies, as well as investors in the life sciences sector. ClearView is guided by principles of clarity, quality, and collaboration, ensuring high-quality solutions developed in partnership with clients. The company fosters an intellectually stimulating environment and attracts motivated individuals through a competitive hiring process.
IMCD Group is a global distributor of specialty chemicals and ingredients, headquartered in Rotterdam, Netherlands. Founded in 1995, the company is listed on the Amsterdam stock exchange and celebrated its 25th anniversary in 2020. IMCD specializes in serving various industries, including pharmaceuticals, food, personal care, coatings, and lubricants, providing formulatory solutions tailored to customer needs. The company has expanded its operations internationally, with significant growth in the Americas, including the establishment of IMCD US in 2015. IMCD Group generates approximately $4.7 billion in revenue and employs around 3,570 people worldwide. Known for its innovative approach and minimal corporate bureaucracy, IMCD maintains strong partnerships with a diverse range of suppliers and customers, from small manufacturers to large corporations.
Were developing tech to feed the world. The world is running out of phosphorus. Most of the worlds phosphorus is used to grow food to feed to animals to produce meat. Manure isnt returned to growing regions, and instead leads to algal blooms and nutrient pollution. Were fixing this problem with tech to produce fertilizer from manure, helping farmers grow better food at a price farmers can afford.